Back to Search Start Over

Structure–activity relationships of anthranilamide-based factor Xa inhibitors containing piperidinone and pyridinone P4 moieties

Authors :
Paul E. Morin
Pancras C. Wong
Darren Orton
Wei Han
Patrick Y.S. Lam
Yun-Long Li
C.-H. Chang
Joseph M. Luettgen
Ruth R. Wexler
James R. Corte
Robert M. Knabb
Mark Hadden
Donald J. P. Pinto
Jolicia F. Gauuan
Zilun Hu
Xiang-Jun Jiang
Tianan Fang
Kan He
Daniel L. Cheney
Alan R. Rendina
Source :
Bioorganic & Medicinal Chemistry Letters. 18:2845-2849
Publication Year :
2008
Publisher :
Elsevier BV, 2008.

Abstract

Introduction of the phenyl piperidinone and phenyl pyridinone P4 moieties in the anthranilamide scaffold led to potent, selective, and orally bioavailable inhibitors of factor Xa. Anthranilamide 28 displayed comparable efficacy to apixaban in the rabbit arteriovenous-shunt (AV) thrombosis model.

Details

ISSN :
0960894X
Volume :
18
Database :
OpenAIRE
Journal :
Bioorganic & Medicinal Chemistry Letters
Accession number :
edsair.doi.dedup.....71f0e123723f0355168a127b067954db